摘要
目的研究葛根素与人血清白蛋白和α1-酸性糖蛋白之间的非共价结合特性。方法应用电喷雾离子阱质谱分别测定葛根素、人血清白蛋白、α1-酸性糖蛋白及其所形成复合物的相对分子质量,通过结合前后的相对分子质量变化计算复合物化学计量比;通过Scatchard方程拟合计算复合物结合常数(K);根据热力学常数△H、△S推测复合物间的作用力类型。结果葛根素与人血清白蛋白、α1-酸性糖蛋白形成的复合物的结合常数分别为7.59×104和8.01×104mol·L-1,最大表观化学结合计量比分别为1∶5和1∶8。葛根素与人血清白蛋白、α1-酸性糖蛋白间的作用力主要为静电引力。结论电喷雾离子阱质谱是一种研究药物与蛋白间非共价结合的灵敏快速和准确的方法。
Abstract
OBJECTIVE To study the noncovalent binding between puerarin (PU) and two plasma proteins,such as human serum albumin(HSA) and α1 -acid glycoprotein(AAG). METHODS The molecular weight of puerarin, human serum albumin,α1-acid glycoprotein and their complexes were measured by the electrospray iontrap mass spectrometry(ESI-MS). The maximum stoichiometric ratios were obtained according to the molecular weight change of the complexes before and after binding reaction, the binding constants of the complexes were calculated by the scatchard equation. The main sorts of binding force of the complexes were deduced according to the relationship between the reaction temperature and the thermodynamic parameters . RESULTS The binding constants(K) and the maximum stoichiometric ratios were 7.59×104mol·L-1,and 1∶5 for PU-HSA,and 8.01×104 mol·L-1 and 1∶8 for PU-AAG, respectively.The main sorts of binding force of the complexes between puerarin and the two plasma proteins were static-electricity gravitation. CONCLUSION ESI-MS is a good method for studying the drug-protein noncovalent binding due to its some advantages in sensitivity, high-speed and accuracy .
关键词
电喷雾离子阱质谱 /
α1-酸性糖蛋白 /
人血清白蛋白 /
葛根素 /
非共价结合
{{custom_keyword}} /
Key words
electrospray ion trap mass spectrometry /
α1-acid glycoprotein /
human serum albumin /
puerarin /
noncovalent binding
{{custom_keyword}} /
祁春华;韩凤梅;曹燚;陈勇.
葛根素与血浆蛋白非共价结合的电喷雾离子阱质谱研究[J]. 中国药学杂志, 2006, 41(23): 1822-1825
QI Chun-hu;HN Feng-mei;CO Yi;CHEN Yong.
Studies on Noncovalent Binding Between Puerarin and Plasma Protein by Electrospray Ion Trap Mass Spectrometry [J]. Chinese Pharmaceutical Journal, 2006, 41(23): 1822-1825
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] LIANG W Q.Biopharmaceutics and Pharmacokinetics（生物药剂学与药物动力学）[M] .Beijing：People’s Medical Press，2003：94-95.
[2] WANG H X，YANG S C.The development of Electrospray ionization mass spectrometry in study of non-covalent protein complexes[J] . Acta Pharm Sin(药学学报)，2001，36(4)：315-320.
[3] OCKEY D A，DOTSONJ L，STRUBLE M E，et al. Structure-activity relationships by mass spectrometry； identification of novel MMP-3 inhibitors[J] .Bioorg Med Chem，2004，12 ：37-42.
[4] SCHLUTER H，JANKOWSKI J，RYKL J，et al. Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system[J] .Anal Bioanal Chem，2003，377：1102-1107.
[5] WANG H X，ZHANG X M，YANG S C.ESI-MS study on non-covalent bond complex of rhFKBP12 and new neurogrowth promoter[J] . Sci Sin C（中国科学C 辑），2002，32（4）：355-360.
[6] SHIELDS S J，OYEYEMI O，SCHMIDT H，et al. Mass spectrometry and non-covalent protein-ligand complexes： confirmation of binding sites and changes in tertiary structure[J] .J Am Soc Mass Spectrom，2003，14： 460-470.
[7] PINKSE M W H，HECK A J R，RUMPEL K，et al . Probing noncovalent protein-ligand interactions of the cGMP-dependent protein kinase using electrospray ionization time of flight mass spectrometry[J] . J Am Soc Mass Spectrom，2004，15：1392-1397.
[8] PESCHKE M，VERKERK U H，KEBARLE P. Features of the ESI mechanism that affect the observation of multiply charged noncovalent protein complexes and the determination of the association constant by the titration method [J] .J Am Soc Mass Spectrom，2004，15：1424-1430.
[9] MCLAFFERTY F W. Tandern mass spectrometry[J] .Sci，198l，214(4518)：280-287.
[10] WANG H L，ZOU H F，ZHANG Y K.Study of competitive binding of drugs to protein by microdialysis/HPLC[J] .Sci Sin B(中国科学B辑)，1998，28（1）：72-74.
[11] WANG Z P，ZHANG Z J，FU Z F，et al. A flow-injection ultrafiltration sampling chemiluminescence system for on-line determination of drug–protein interaction[J] .Anal Bioanal Chem，2003，377：660-667.
[12] SARKAR B.Metal Ions In Biological System[M] .New York：Marcel Dekker，1991：232.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
湖北省杰出青年基金项目(2002AC004);中药生物技术省重点实验室开放基金项目(040106)
{{custom_fund}}
